Clinal trial abt COVID-19 vaccine information in Japanese 治験中の枠沈情報

モデルナ、ファイザーのコロナ枠沈における、妊娠者への治験についての情報

☪️モデルナ
Moderna COVID-19 Vaccine in Pregnant Women
The Moderna COVID-19 Vaccine Pregnancy Registry will collect primary data from pregnant women who have received the Moderna COVID-19 vaccine and their healthcare providers (HCPs).

✳️ファイザー
This will be a Phase 2/3, randomized, placebo-controlled, observer-blind study evaluating the safety, tolerability, and immunogenicity of 30 µg of BNT162b2 or placebo administered in 2 doses, 21 days apart, in approximately 700 healthy pregnant women 18 years of age or older vaccinated at 24 to 34 weeks' gestation. Participants will be randomized 1:1 to receive BNT162b2 or placebo (saline).